Sometimes, weight gain during semaglutide treatment is linked to other health issues such as hypothyroidism, hormonal imbalances, or fluid retention
Negli ultimi anni, i farmaci agonisti del recettore GLP-1 come la semaglutide e i co-agonisti GLP-1 / GIP come la tirzepatide hanno trasformato il trattamento dellobesit
Heres how we approach GLP-1related shedding: Detailed History and Scalp Evaluation We start by understanding the full picture: Which GLP-1 youre on, when you started, and how your dose has changed How much weight youve lost and over what time frame Your current eating patterns, protein intake, and supplements Other medical conditions, medications, or recent stressors Family history of hair loss We then perform a targeted scalp exam
Lets break down each piece
Cardiovascular outcomes included composite endpoints as asserted in the Methods section and Figure 3 ascertains the reduction in those events, individual trials aligned with the cardioprotective benefits of SGLT inhibitor therapy
